Invesco Ltd. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$687,465
-32.5%
151,091
+4.5%
0.00%
Q2 2023$1,018,252
+17.2%
144,638
+1.7%
0.00%
Q1 2023$868,774
+40.4%
142,189
+46.9%
0.00%
Q4 2022$618,642
-33.6%
96,814
-0.4%
0.00%
Q3 2022$931,000
-94.9%
97,178
-94.1%
0.00%
-100.0%
Q2 2022$18,087,000
-34.6%
1,638,255
-1.4%
0.01%
-28.6%
Q1 2022$27,661,000
-8.7%
1,661,292
+4.7%
0.01%0.0%
Q4 2021$30,297,000
+19.7%
1,587,067
+54.6%
0.01%
+16.7%
Q3 2021$25,317,000
-5.9%
1,026,657
-0.7%
0.01%
-14.3%
Q2 2021$26,915,000
-27.2%
1,034,365
-11.4%
0.01%
-30.0%
Q1 2021$36,975,000
-50.4%
1,167,872
-27.2%
0.01%
-54.5%
Q4 2020$74,484,000
+43.4%
1,605,263
+1.7%
0.02%
+22.2%
Q3 2020$51,942,000
+54.5%
1,577,816
+28.8%
0.02%
+50.0%
Q2 2020$33,622,000
+511.1%
1,224,821
+566.3%
0.01%
+500.0%
Q1 2020$5,502,000
+71.5%
183,826
+58.6%
0.00%
+100.0%
Q4 2019$3,209,000
-2.0%
115,931
-13.2%
0.00%0.0%
Q2 2019$3,276,000
-18.8%
133,591
-57.6%
0.00%0.0%
Q2 2018$4,036,000315,3300.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Perceptive Advisors 11,826,299$130,562,0004.09%
MPM BioImpact LLC 1,200,000$13,248,0003.68%
Finepoint Capital LP 960,200$10,601,0003.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,011$273,000,0002.85%
Avoro Capital Advisors LLC 9,220,000$101,789,0002.01%
Long Focus Capital Management, LLC 1,625,000$17,940,0001.88%
683 Capital Management, LLC 2,000,000$22,080,0001.56%
Parametrica Management Ltd 115,870$1,268,0001.38%
Boxer Capital, LLC 1,935,133$21,364,0001.35%
Soleus Capital Management, L.P. 719,600$7,944,0001.24%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders